NCT06383338View on ClinicalTrials.gov

A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 22, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Hodgkin LymphomaNon Hodgkin Lymphoma
Interventions
DRUG

Omeprazole

Sub-therapeutic probe drug administration to measure phenoconversion.

DRUG

Dextromethorphan

Sub-therapeutic probe drug administration to measure phenoconversion.

Trial Locations (1)

3000

RECRUITING

Peter MacCallum Cancer Centre, Melbourne

Sponsors
All Listed Sponsors
lead

Murdoch Childrens Research Institute

OTHER

NCT06383338 - A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma. | Biotech Hunter | Biotech Hunter